Amneal Pharmaceuticals Inc (AMRX)
5.89
-0.05
(-0.84%)
USD |
NASDAQ |
Apr 30, 09:42
Amneal Pharmaceuticals 1 Year Total Returns (Daily): 207.8% for April 29, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 29, 2024 | 207.8% |
April 26, 2024 | 224.3% |
April 25, 2024 | 245.0% |
April 24, 2024 | 245.7% |
April 23, 2024 | 231.3% |
April 22, 2024 | 229.4% |
April 19, 2024 | 211.5% |
April 18, 2024 | 226.8% |
April 17, 2024 | 230.9% |
April 16, 2024 | 300.7% |
April 15, 2024 | 307.4% |
April 12, 2024 | 315.0% |
April 11, 2024 | 306.4% |
April 10, 2024 | 310.1% |
April 09, 2024 | 309.3% |
April 08, 2024 | 328.6% |
April 05, 2024 | 356.7% |
April 04, 2024 | 338.2% |
April 03, 2024 | 315.2% |
April 02, 2024 | 318.0% |
April 01, 2024 | 335.3% |
March 28, 2024 | 377.2% |
March 27, 2024 | 374.4% |
March 26, 2024 | 339.8% |
March 25, 2024 | 344.4% |
Date | Value |
---|---|
March 22, 2024 | 336.7% |
March 21, 2024 | 311.1% |
March 20, 2024 | 325.2% |
March 19, 2024 | 343.4% |
March 18, 2024 | 313.3% |
March 15, 2024 | 304.4% |
March 14, 2024 | 276.9% |
March 13, 2024 | 267.3% |
March 12, 2024 | 247.1% |
March 11, 2024 | 251.6% |
March 08, 2024 | 220.8% |
March 07, 2024 | 201.7% |
March 06, 2024 | 191.8% |
March 05, 2024 | 178.1% |
March 04, 2024 | 181.2% |
March 01, 2024 | 161.7% |
February 29, 2024 | 168.0% |
February 28, 2024 | 168.0% |
February 27, 2024 | 164.4% |
February 26, 2024 | 167.0% |
February 23, 2024 | 160.1% |
February 22, 2024 | 156.3% |
February 21, 2024 | 147.0% |
February 20, 2024 | 137.9% |
February 16, 2024 | 147.9% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.05%
Minimum
Aug 27 2019
377.2%
Maximum
Mar 28 2024
1.68%
Average
-16.02%
Median
1 Year Total Returns (Daily) Benchmarks
Fate Therapeutics Inc | -33.44% |
Ocular Therapeutix Inc | -22.58% |
Editas Medicine Inc | -34.19% |
AnaptysBio Inc | 2.31% |
Stoke Therapeutics Inc | 33.41% |